{"disease":{"id":"refractory-meningioma","name":"refractory meningioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04239092","title":"9-ING-41 in Pediatric Patients With Refractory Malignancies.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Actuate Therapeutics Inc.","has_results":false},{"nct_id":"NCT05537675","title":"Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}